A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

NCT01235559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

604

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Placebo
DRUG: bitopertin [RO4917838] level 1
DRUG: bitopertin [RO4917838] level 2

Sponsor

Hoffmann-La Roche